AMEX : CMT

Core Molding Technologies, Inc.

$24.68 USD

$1.08 (4.58%)

Volume
22.09K
Average Volume
30.8K
Market Capitalization
$219.65M
P/E Ratio
22.02
Dividend Yield
0.00%
Price Target
$24.00
Year High
$28.69
Year Low
$16.37
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.41
Source Headline
Core Molding Technologies Announces Timing of Its Fiscal 2026 Second Quarter Results

COLUMBUS, Ohio, July 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty trucks, powersports, building products, and industrial and utility industries across North America, today announces that it will release its second quarter fiscal 2026 results on Tuesday, August 4, 2026, before the market opens. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet the same day at 10:00am Eastern.

globenewswire.com - 2026-07-14 16:10:00

Core Molding Technologies Extends Credit Facility Through 2031, Increasing Financial Flexibility for Strategic Growth

COLUMBUS, Ohio, July 07, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utility industries across the United States, Canada, and Mexico, today announced the successful amendment and extension of its credit agreement through 2031. The amended credit facility consists of a $50 million delayed draw term loan and a $50 million revolving credit facility.

globenewswire.com - 2026-07-07 08:00:00

SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting

Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT exploratory study evaluating ignaseclant in patients living with Charcot-Marie-Tooth disease (CMT) types 1 or 2 has been presented in a late-breaking oral presentation at the 2026 Peripheral Neuroscience Association (PNS) Annual Meeting held in Maastricht, The Netherlands from June 13-16, 2026. The late-breaking presentation was given by David Herrmann, MD, Chief of the Neuromuscular Division and Vice Chair for Strategic Initiatives in the Department of Neurology at the University of Rochester Medical Center on Sunday, June 14, 2026.

globenewswire.com - 2026-06-17 01:00:00

Cullinan Metals Launches New Corporate Website and Announces Strategic Repositioning

VANCOUVER, BC – TheNewswire - June 01, 2026 – Cullinan Metals Corp. (the “Company”) (CSE: CMT) (OTCQB: CNTMF) (FSE: 7KO) is pleased to announce the launch of its new corporate website, reflecting the Company's evolving strategic direction and renewed focus on emerging resource opportunities and advanced technologies. The new website is now available at: www.cullinanmetalscorp.com

thenewswire.com - 2026-06-01 09:00:00

Core Molding Technologies Looks For A Good 2026/2027 But Remains Aggressively Priced

Core Molding Technologies reported 1Q26 results showing pressured trucking revenues offset by strength in industrial, EV, and BESS segments. CMT maintains robust gross margins (~20%) and expects 17–19% for the year, with adjusted operating income potentially reaching $20 million in 2026. Management anticipates a trucking cycle recovery and sales upside from the expanded Matamoros facility in 2H26, but near-term revenue growth remains muted.

seekingalpha.com - 2026-05-28 03:20:26

The Russell 2000 Is Up 31% and These 2 Small Cap Stocks Under $30 Have the Fundamentals to Keep Running

Small caps are finally getting their moment. The iShares Russell 2000 ETF (NYSEARCA:IWM | IWM Price Prediction) is up 12.11% year to date and 31.51% over the past year, a sharp rotation away from the mega-cap trade that dominated the prior cycle.

247wallst.com - 2026-05-19 11:11:10

Core Molding Technologies to Present and Host 1x1 Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10, 2026

COLUMBUS, Ohio, May 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that management will participate in the 16th Annual East Coast IDEAS Investor Conference at The Westin New York at Times Square. The Company will host one-on-one investor meetings throughout the day, with their presentation scheduled for 3:20-3:55 PM ET on June 10th.

globenewswire.com - 2026-05-14 16:05:00

Core Molding Technologies, Inc. (CMT) Q1 2026 Earnings Call Transcript

Core Molding Technologies, Inc. (CMT) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-08 02:11:15

Core Molding Technologies (CMT) Misses Q1 Earnings and Revenue Estimates

Core Molding Technologies (CMT) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.25 per share a year ago.

zacks.com - 2026-05-07 12:16:33

Core Molding Technologies Reports Fiscal 2026 First Quarter Results

First Quarter Delivers New Wins of $17 million, Margin Expansion, Strategic Investment Progress, and Early Signs of Cycle Recovery First Quarter Delivers New Wins of $17 million, Margin Expansion, Strategic Investment Progress, and Early Signs of Cycle Recovery

globenewswire.com - 2026-05-07 08:00:00

Core Molding Technologies (NYSEAMERICAN:CMT) Shares Cross Above 50-Day Moving Average – What’s Next?

Shares of Core Molding Technologies Inc (NYSEAMERICAN:CMT - Get Free Report) crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $21.00 and traded as high as $27.93. Core Molding Technologies shares last traded at $27.27, with a volume of 58,380 shares changing hands.

defenseworld.net - 2026-04-18 04:09:45

Get CMT Insider Trade Alerts

CMT Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$24.00

1 analysts

All Time

$24.33

3 analysts

CMT Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-03-11 Roth Capital Maintain Buy Buy
2024-05-08 EF Hutton Maintain Buy Buy
2024-03-13 EF Hutton Maintain Buy Buy
2023-11-07 EF Hutton Maintain Buy Buy
2023-08-08 EF Hutton Maintain Buy Buy
2023-05-10 EF Hutton Maintain Buy Buy
2023-03-14 EF Hutton Maintain Buy Buy
2022-08-10 EF Hutton Maintain Buy Buy
2022-07-18 EF Hutton Maintain Buy Buy